Afimoxifene

N/A

Report date: 2024/12/13 13:53:48
NME

Base Information

Drug NameAfimoxifene
Drug Alias Name阿非昔芬Afimoxifenum4-Hydroxytamoxifen4-OH tamoxifenAfimoxifeno +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors antagonists
TargetsEstrogen receptors
Therapy Area/IndicationsMastodyniaBreast NeoplasmsCarcinoma, Intraductal, Noninfiltrating +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer InstituteNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteNorthwestern University
Inactive CompaniesAscend Therapeutics
Active IndicationsBreast NeoplasmsCarcinoma, Intraductal, Noninfiltrating
Inactive IndicationsMastodyniaNeoplasms

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG